aptaTargets is a startup based in Spain, 1 tracked investor.
aptaTargets is a company founded in 2016 headquartered in Spain. Brouky records 1 investor associated with the company.
aptaTargets is a clinical-stage biotech company developing innovative therapies for acute neurological diseases. Their lead compound, ApTOLL, is an RNA aptamer targeting Toll-like receptor 4, currently in Phase IIb clinical trials for acute ischemic stroke.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.